Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats

Neurochemistry International

Volumn 57, Issue 3, 2010, Pages 189-197

  Könczöl, Katalin ^a   Bodnár, Ibolya ^a,b   Zelena, Dóra ^a   Pintér, Ottó ^a   Papp, Rege Sugárka ^a   Palkovits, Miklós ^a   Nagy, György M ^a,b   Tóth, Zsuzsanna E ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

ACTH; Adrenalectomy; Corticosterone; Fos; In situ hybridzation; Restraint

Indexed keywords

BRAIN PROTEIN; CORTICOSTERONE; CORTICOTROPIN; PROTEIN FOS; PROTEIN NESFATIN 1; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; MESSENGER RNA; NERVE PROTEIN; NUCLEOBINDIN; PROLACTIN RELEASING FACTOR; PROTEIN C FOS; TYROSINE 3 MONOOXYGENASE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EXERCISE; GENETICS; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CORTICOSTERONE; DNA-BINDING PROTEINS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; PROLACTIN-RELEASING HORMONE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 77955093801     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.04.012     Document Type: Article

References (39)

1. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 1994, 15:321-350.
2. Bernardini R., Chiarenza A., Kamilaris T.C., Renaud N., Lempereur L., Demitrack M., Gold P.W., Chrousos G.P. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology 1994, 60:503-508.
3. Bodnar I., Banky Z., Zelena D., Halasz B. Glutamate receptor antagonist infused into the hypothalamic suprachiasmatic nuclei interferes with the diurnal fluctuations in plasma prolactin and corticosterone levels and injected into the mesencephalic dorsal raphe nucleus attenuates the suckling stimulus-induced release of prolactin of the rat. Brain Res. Bull. 2009, 80:9-16.
4. Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., Dun N.J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007, 148:5088-5094.
5. Cunningham J.J., Calles-Escandon J., Garrido F., Carr D.B., Bode H.H. Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats. Endocrinology 1986, 118:98-101.
6. Dallman M.F., Pecoraro N.C., La Fleur S.E., Warne J.P., Ginsberg A.B., Akana S.F., Laugero K.C., Houshyar H., Strack A.M., Bhatnagar S., Bell M.E. Glucocorticoids, chronic stress, and obesity. Prog. Brain Res. 2006, 153:75-105.
7. Foo K.S., Brismar H., Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008, 156:563-579.
8. Fort P., Salvert D., Hanriot L., Jego S., Shimizu H., Hashimoto K., Mori M., Luppi P.H. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 2008, 155:174-181.
9. Goebel M., Stengel A., Wang L., Lambrecht N.W., Tache Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci. Lett. 2009, 452:241-246.
10. Goebel M., Stengel A., Wang L., Tache Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res. 2009, 1300:114-124.
11. Harris R.B., Mitchell T.D., Simpson J., Redmann S.M., Youngblood B.D., Ryan D.H. Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R77-R88.
12. Kovacs K.J. Functional neuroanatomy of the parvocellular vasopressinergic system: transcriptional responses to stress and glucocorticoid feedback. Prog. Brain Res. 1998, 119:31-43.
13. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
14. Lightman S.L. The neuroendocrinology of stress: a never ending story. J. Neuroendocrinol. 2008, 20:880-884.
15. Ma X.M., Levy A., Lightman S.L. Rapid changes in heteronuclear RNA for corticotrophin-releasing hormone and arginine vasopressin in response to acute stress. J. Endocrinol. 1997, 152:81-89.
16. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh I.S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009, 10:355-365.
17. Makara G.B., Kovacs K.J. Lesioning of the hypothalamic paraventricular nucleus inhibits ether-induced ACTH but not prolactin release. Neurobiology (Bp) 1997, 5:403-411.
18. Maruyama M., Matsumoto H., Fujiwara K., Noguchi J., Kitada C., Fujino M., Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 2001, 142:2032-2038.
19. Mera T., Fujihara H., Kawasaki M., Hashimoto H., Saito T., Shibata M., Saito J., Oka T., Tsuji S., Onaka T., Ueta Y. Prolactin-releasing peptide is a potent mediator of stress responses in the brain through the hypothalamic paraventricular nucleus. Neuroscience 2006, 141:1069-1086.
20. Merali Z., Cayer C., Kent P., Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl.) 2008, 201:115-123.
21. Morgan J.I., Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 1989, 12:459-462.
22. Oh I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
23. Okere, B., Xu, L., Roubos, E.W., Sonetti, D., Kozicz, T., 2010. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res. 1317, 92-99.
24. Pacak K., Palkovits M., Kvetnansky R., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: a microdialysis study. Neuroendocrinology 1993, 58:196-201.
25. Petrov T., Krukoff T.L., Jhamandas J.H. Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res. 1993, 609:81-92.
26. Price C.J., Hoyda T.D., Samson W.K., Ferguson A.V. Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J. Neuroendocrinol. 2008, 20:245-250.
27. Raptis S., Fekete C., Sarkar S., Rand W.M., Emerson C.H., Nagy G.M., Lechan R.M. Cocaine- and amphetamine-regulated transcript co-contained in thyrotropin-releasing hormone (TRH) neurons of the hypothalamic paraventricular nucleus modulates TRH-induced prolactin secretion. Endocrinology 2004, 145:1695-1699.
28. Saha S. Role of the central nucleus of the amygdala in the control of blood pressure: descending pathways to medullary cardiovascular nuclei. Clin. Exp. Pharmacol. Physiol. 2005, 32:450-456.
29. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. 1982, 257:275-325.
30. Stengel, A., Goebel, M., Wang, L., Tache, Y., 2010. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides 31, 263-270.
31. Sun B., Fujiwara K., Adachi S., Inoue K. Physiological roles of prolactin-releasing peptide. Regul. Pept. 2005, 126:27-33.
32. Tan Z., Nagata S. PVN c-fos expression, HPA axis response and immune cell distribution during restraint stress. J. UOEH 2002, 24:131-149.
33. Toth Z.E., Gallatz K., Fodor M., Palkovits M. Decussations of the descending paraventricular pathways to the brainstem and spinal cord autonomic centers. J. Comp. Neurol. 1999, 414:255-266.
34. Toth Z.E., Zelena D., Mergl Z., Kirilly E., Varnai P., Mezey E., Makara G.B., Palkovits M. Chronic repeated restraint stress increases prolactin-releasing peptide/tyrosine-hydroxylase ratio with gender-related differences in the rat brain. J. Neurochem. 2008, 104:653-666.
35. Viau V., Sawchenko P.E. Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress: rapid publication. J. Comp. Neurol. 2002, 445:293-307.
36. Young W.S., Mezey E., Siegel R.E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 1986, 70:198-203.
37. Zelena D., Foldes A., Mergl Z., Barna I., Kovacs K.J., Makara G.B. Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats. Brain. Res. Bull. 2004, 63:521-530.
38. Zelena D., Kiem D.T., Barna I., Makara G.B. Alpha 2-adrenoreceptor subtypes regulate ACTH and beta-endorphin secretions during stress in the rat. Psychoneuroendocrinology 1999, 24:333-343.
39. Zelena D., Mergl Z., Foldes A., Kovacs K.J., Toth Z., Makara G.B. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E1110-E1117.